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To the Editor: Abdominal tubers
culosis continues to be a significant 
health problem in the developing 
world. Recently there has been an 
increase in the number of cases in 
those parts of world where it was 
rare due to increasing travel and 
migration and also due to a riss
ing number of HIV cases who 
are predisposed to opportunistic 
infections.1 Several reports have 
highlighted the remarkable similars
ity between this illness and ovarian 
carcinoma.2 We report a case with 
ascites, pleural effusion and abdoms
inocervical lymphadenopathy and 
bilateral cystic ovarian lesions and 
elevated CAs125 which could have 
been treated as ovarian carcinoma 
and subjected to surgical resections 
and chemotherapy and their conses
quences.
A 47syearsold multiparous pres
menopausal woman presented with 
progressive abdominal distension 
of 4 weeks duration without any 
history of altered bowl habits, fes
ver or any significant medical hiss
tory. Examination revealed two 
mobile 2.5scm rightssided cervical 
lymph nodes, right pleural effus
sion and ascites. Complete blood 
counts, kidney and liver functions 
were normal. ESR was 45 mm and 
ascitic and pleural fluid analysis res
vealed exudative lymphocyte pres
dominant ascitic fluid. Cytology 
was negative for any malignant cells 
as was ascetic and pleural fluid AFB 
staining. Ultrasonography revealed 
ascites, bilateral 2scm3 cystic lesions 
in the ovaries and a normal liver, 
spleen, and kidneys. CT scan of the 
chest revealed right pleural effusion 
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(Figure 1) and a normal mediastis
num. CT scan of the abdomen res
vealed ascites, multple paraaortic, 
paracaval, paracelial lymph nodes 
of variable size and confirmed bis
lateral ovarian cysts (Figures 2, 3). 
Upper and lower GIT endoscopies 
were normal as was barium follows
through. The possibility of ovarian 
carcinoma, lymphoma and tubercus
losis were considered. A Mantoux 
test was negative. CAs125 levels of 
531 Mu/L (0s35 normal) increased 
the suspicion for ovarian carcinoma. 
However, excisional biopsy of the 
cervical lymph nodes revealed cases
ous lymphadenitis (Figure 4). The 
patient was started on a foursdrug 
regimen of antitubercular drugs, and 
within 4 weeks, ascites and pleural 
effusion disappeared. The patient 
was followed regularly and after 4 
months of therapy a CT scan of the 
chest and abdomen were repeated, 
and revealed no pleural effusion, no 
ascites, resolved abdominal lymphs
adenitis and persistent samessized 
ovarian cystic lesions (Figures 5, 6). 
CAs125 was repeated and had des
creased to 36.1 Mu/L. At that point 
the patient was doing well and was 
asymptomatic.
Tuberculosis continues to be an 
endemic disease in the developing 
countries.1 The risk factors for the 
development of tuberculosis include 
immigration, low income populas
tions, immunosuppression, HIV, 
and living in close contact with pas
tients suffering from tuberculosis.1,2 
Disseminated tuberculosis accounts 
for 1% to 3% of cases that suffer from 
tuberculosis.3 Peritoneal tuberculos
sis has symptoms in common with 
advanced ovarian carcinoma. Pelvic 
pain and mass, ascites, and elevated 
serum CAs125 are wellsknown 
markers for ovarian cancer and for 
peritoneal tuberculosis. There are 
several case reports that point out 
the uncertainty in the preoperative 
differential diagnosis of peritoneal 
Figure	1.	right pleural effusion before 
treatment.
Figure	2.	parabaortic lymph nodes before 
treatment.
Figure	3.	ascites.
tuberculosis and advanced ovarian 
cancer.1s15
Our patient presented with ascis
tes, pleural effusion and abdominal 
lymph adenopathy. The difficult 
problem was to go for laparotomy, 
especially in the presence of bilaters
al cystic ovarian lesions and elevated 
CAs125. Elevation of CAs125 in 
peritoneal tuberculosis has been 
reported and misinterpreted with 
disseminated ovarian cancer with 
laprotomies and extensive surgis
cal resections.16s20 The presence of 
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a cervical lymph node and its excis
sional biopsy prevented our patient 
from laparotomy and/or surgery 
and chemotherapy. The positive 
predictive value of the serum CAs
125 to detect malignancy has been 
estimated at 60% generally, rising to 
98% in postmenopausal women.6,8 
The sensitivity and specificity of 
the CAs125 declines in the pres
menopausal age groups, presums
ably because of the high incidence 
of benign conditions that can cause 
elevation of this marker.6 For this 
reason, in young patients with els
evated serum CAs125 levels, tubers
culosis should be considered in the 
differential diagnosis, especially in 
areas where tuberculosis is endems
ic.2,8 Furthermore, CAs125 levels 
seem to serve as a potential follows
up marker of the disease activity in 
benign disease like tuberculosis.21s23 
This was seen in our case also and 
the fall in CAs125 paralleled clinical 
and radiological improvement.
In conclusion, tuberculosis must 
always be considered in premenos
pausal women with low socioecos
nomic status, who are living in ens
demic areas of tuberculosis and with 
presenting signs of ovarian cancer 
like a pelvic mass, ascites, serum 
CA125 elevation, pleural effusion 
and abdominal lymphadenopathy. 
CA125 can be useful marker in the 
follow up of a benign disease like 
tuberculosis.
